Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Racadot

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic LeukemiaC Sebban, E Lepage, J P Vernant, et al.
Blood|June 15, 1992
Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host diseaseP Hervé, M Flesch, P Tiberghien, et al.
Transplantation|September 1, 1991
Soluble CD8, IL-2 receptor, and tumor necrosis factor-alpha levels in steroid-resistant acute graft-versus-host disease. Relation with subsequent response to anti-IL-2 receptor monoclonal antibody treatmentP Tiberghien, E Racadot, B Lioure, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1995
Herpes virus-related lymphoproliferative disorders following allogeneic bone marrow transplantation: clinical and biological characteristics of six casesA Brion, J Y Cahn, C Mougin, et al.
Cancer|May 15, 1992
Interleukin-2-induced increase of a monoclonal B-cell lymphocytosis. A novel in vivo interleukin-2 effect?P Tiberghien, E Racadot, M L Deschaseaux, et al.
Leukemia & Lymphoma|November 1, 1993
Graft failure after T cell depleted HLA identical allogeneic bone marrow transplantation: risk factors in leukemic patientsM Delain, J Y Cahn, E Racadot, et al.
Transplantation Proceedings|February 1, 1991
Use of monoclonal antibodies in vivo as a therapeutic strategy for acute GvHD in matched and mismatched bone marrow transplantationP Herve, P Bordigoni, J Y Cahn, et al.
British Journal of Haematology|July 1, 1988
Marrow transplantation from HLA non-identical family donors for the treatment of leukaemia: a pilot study of 15 patients using additional immunosuppression and T-cell depletionJ Y Cahn, P Herve, M Flesch, et al.
Blood|April 1, 1993
Interleukin-1 administration before lethal irradiation and allogeneic bone marrow transplantation: early transient increase of peripheral granulocytes and successful engraftment with accelerated leukocyte, erythrocyte, and platelet recoveryP Tiberghien, V Laithier, M Mabed, et al.
Transplantation|February 1, 1985
Removal of marrow T cells with OKT3-OKT11 monoclonal antibodies and complement to prevent acute graft-versus-host disease. A pilot study in ten patientsP Herve, M Flesch, J Y Cahn, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic LeukemiaC Sebban, E Lepage, J P Vernant, et al.
Blood|June 15, 1992
Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host diseaseP Hervé, M Flesch, P Tiberghien, et al.
Transplantation|September 1, 1991
Soluble CD8, IL-2 receptor, and tumor necrosis factor-alpha levels in steroid-resistant acute graft-versus-host disease. Relation with subsequent response to anti-IL-2 receptor monoclonal antibody treatmentP Tiberghien, E Racadot, B Lioure, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1995
Herpes virus-related lymphoproliferative disorders following allogeneic bone marrow transplantation: clinical and biological characteristics of six casesA Brion, J Y Cahn, C Mougin, et al.
Cancer|May 15, 1992
Interleukin-2-induced increase of a monoclonal B-cell lymphocytosis. A novel in vivo interleukin-2 effect?P Tiberghien, E Racadot, M L Deschaseaux, et al.
Leukemia & Lymphoma|November 1, 1993
Graft failure after T cell depleted HLA identical allogeneic bone marrow transplantation: risk factors in leukemic patientsM Delain, J Y Cahn, E Racadot, et al.
Transplantation Proceedings|February 1, 1991
Use of monoclonal antibodies in vivo as a therapeutic strategy for acute GvHD in matched and mismatched bone marrow transplantationP Herve, P Bordigoni, J Y Cahn, et al.
British Journal of Haematology|July 1, 1988
Marrow transplantation from HLA non-identical family donors for the treatment of leukaemia: a pilot study of 15 patients using additional immunosuppression and T-cell depletionJ Y Cahn, P Herve, M Flesch, et al.
Blood|April 1, 1993
Interleukin-1 administration before lethal irradiation and allogeneic bone marrow transplantation: early transient increase of peripheral granulocytes and successful engraftment with accelerated leukocyte, erythrocyte, and platelet recoveryP Tiberghien, V Laithier, M Mabed, et al.
Transplantation|February 1, 1985
Removal of marrow T cells with OKT3-OKT11 monoclonal antibodies and complement to prevent acute graft-versus-host disease. A pilot study in ten patientsP Herve, M Flesch, J Y Cahn, et al.
Pageof 10